MELISSA MCCLENAHAN: Open Payments
NPI 1053695676 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,174 in 64 payments from 18 companies in 2025. Trend: 2023 $2,150 · 2024 $621 · 2025 $15,174
Speaker / faculty: $7,820Travel & lodging: $5,757Food & beverage: $1,347Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 30 | $14,134 |
| ABBVIE INC. | 2 | $372 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $137 |
| Endo USA, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Olympus America Inc. | 3 | $47 |
| ACCORD HEALTHCARE, INC. | 3 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| BLUEWIND MEDICAL | 1 | $39 |
Products named: RYBREVANT, BOTOX, ERLEADA, Nubeqa, Auvelity, AVEED, ORGOVYX, iTIND System.
Industry payments across ID — which companies pay providers there.
